Status | Study |
NOT_YET_RECRUITING |
Study Name: Study to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive Osteosarcoma Condition: Osteosarcoma Date: 2022-09-14 Interventions: Vactosertib is given twice a day, five days on and two days off in four-week cycles.Vactosertib is a transforming growth factor-beta (TGF-?) typ |
Recruiting |
Study Name: Clinical Trial Evaluating Metronomic Chemotherapy in Patients With Metastatic Osteosarcoma Condition: Osteosarcoma Date: 2017-01-27 Interventions: Drug: Cyclophosphamide Continu |
Not yet recruiting |
Study Name: A Study of Pembrolizumab in Patients With Relapsed Or Metastatic Osteosarcoma Not Eligible for Curative Surgery Condition: Osteosarcoma Date: 2017-01-04 Interventions: Drug: Pembrolizumab Pembrolizumab is a humanized antibody used in cancer immunotherapy. |
Completed |
Study Name: Trial With Gemcitabine and Rapamycin in Second Line of Metastatic Osteosarcoma Condition: Osteosarcoma Date: 2015-04-24 Interventions: Drug: Gemcitabine plus rapamycin Gemcitabine and rapamycin given in combination |
Completed |
Study Name: A Eurosarc Study of Mifamurtide in Advanced Osteosarcoma (MEMOS) Condition: Osteosarcoma Date: 2015-03-16 Interventions: Drug: Mifamurtide Drug: Ifosfamide |
Recruiting |
Study Name: Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma Condition: Metastatic Osteosarcoma Date: 2013-06-04 Interventions: Drug: Sm-EDTMP Subjects receiv |
Completed |
Study Name: Genetic Biomarkers in Tissue Samples From Patients With Osteosarcoma Condition: Osteosarcoma Date: 2013-03-06 Interventions: Other: laboratory biomarker analysis Correlative studies |
Recruiting |
Study Name: Diffusion Study on Patients With Osteosarcoma Condition: Osteosarcoma Date: 2012-06-06 |
Recruiting |
Study Name: ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma Condition: Osteosarcoma Date: 2011-10-19 Interventions: Drug: Mifamurtide arm |
Completed |
Study Name: Outpatient Administration of High Dose Methotrexate (HD MTX) in Patients With Osteosarcoma Condition: Osteosarcoma Date: 2010-08-03 Interventions: Drug: High Dose Methotrexate Methotrexate will be given by |